A phase IV, multi-center, randomized, open-label study of PCECV (Rabipur) comparing the immunogenicity and safety of two different simulated post exposure schedules (Zagreb 2-1-1 versus Essen regimen 1-1-1-1-1) in Healthy Indian subjects - Rabipur study.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Pharmacodynamics
- Sponsors Novartis
- 02 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Aug 2011 New source identified and integrated (Clinical Trials Registry - India).
- 22 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.